Baxter International
Baxter International Inc. (NYSE: BAX) provides healthcare products for hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, medical offices, dialysis centers and patients at home under physician supervision. Its portfolio includes sterile intravenous solutions, infusion systems, parenteral… From the company’s description.
In fiscal 2025, Baxter International reported revenue of $11.24B, up 5.7% from fiscal 2024, and a net loss of $900.00M. Its operating margin was −2.7%, and operations generated $845.00M in cash. Over the twelve months to Jun 30, 2026, revenue was $11.47B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Baxter International does
In the company’s own words
Baxter International Inc. (NYSE: BAX) provides healthcare products for hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, medical offices, dialysis centers and patients at home under physician supervision. Its portfolio includes sterile intravenous solutions, infusion systems, parenteral nutrition therapies, injectable pharmaceuticals, inhaled anesthetics, surgical products and equipment, smart beds, patient monitoring and diagnostic technologies, and respiratory devices. Baxter organizes its business into three reportable segments: Medical Products & Therapies, covering IV solutions, infusion systems, nutrition therapies and surgical products; Healthcare Systems & Technologies, covering connected care, monitoring, diagnostic, respiratory and surgical technologies; and Pharmaceuticals, covering specialty injectables, inhaled anesthetics and drug compounding services. Following the 2025 sale of its Kidney Care business and the 2023 sale of BioPharma Solutions, Baxter manufactured products in more than 20 countries and sold them in more than 100 countries as of December 31, 2025. It employed approximately 37,500 people worldwide at that date. Its website is www.baxter.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- DEERFIELD, IL
- Fiscal year end
- December
- CIK
- 10456
- SIC
- 3841
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Baxter International — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Baxter International · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Baxter International’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Baxter International’s bonds, as funds hold them
Funds report holding 15 issues of Baxter International’s debt, $2.01B at market value — what funds hold, not the company’s total debt. Weighted-average coupon 3.67%, maturing 2026 to 2051.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Baxter International and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Baxter International's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Baxter International's last four quarterly filings that the numbers alone won't show?”